2013 annual hematology meeting: lymphoma - rituximab maintenance therapy
Published 10 years ago • 675 plays • Length 9:52Download video MP4
Download video MP3
Similar videos
-
11:48
2013 annual hematology meeting: lymphoma - lenalidomide
-
11:43
2013 annual hematology meeting: lymphoma - ibrutinib & idelalisib
-
16:18
2013 annual hematology meeting: cll - upfront therapy
-
16:04
2013 annual hematology meeting: multiple myeloma - maintenance and relapse
-
21:42
2013 annual hematology meeting: multiple myeloma - upfront therapy
-
25:33
2013 annual hematology meeting: cml - clinical trial updates
-
19:11
is there long term benefit from maintenance rituximab for lymphoma patients?
-
15:28
2013 annual hematology meeting: cll - relapsed disease
-
10:47
2013 annual hematology meeting: cll - novel agents
-
14:31
2013 annual hematology meeting: cml - novel agents and new trials
-
19:55
2013 annual hematology meeting: multiple myeloma - novel agents
-
17:32
debate: should maintenance rituximab be used in follicular lymphoma? - yes
-
14:02
debate: is obinutuzumab superior to rituximab in lymphoma? - no
-
1:30
ash 2014: phase iii lyma trial of rituximab maintenance after asct in mantle cell lymphoma
-
19:14
best of the day: from the 2016 annual hematology meeting - lymphoma
-
12:52
debate: is obinutuzumab superior to rituximab in lymphoma? - yes
-
2:03
dr. lugtenburg on maintenance rituximab in dlbcl
-
18:21
do we really need to transplant young patients with mantle cell lymphoma?